ProfileGDS4718 / 205158_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 86% 86% 87% 91% 90% 83% 83% 92% 87% 92% 90% 86% 83% 79% 82% 97% 94% 90% 88% 70% 93% 93% 93% 90% 91% 88% 92% 57% 87% 77% 93% 83% 90% 90% 86% 88% 87% 90% 89% 88% 86% 76% 85% 91% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.6352886
GSM549102patient 115, normal, homogenized [OPG study]8.5352586
GSM549104patient 119, normal, homogenized [OPG study]8.7863687
GSM549108patient 138, normal, homogenized [OPG study]9.3169491
GSM549119patient 077, normal, homogenized [OPG study]9.1951890
GSM549133patient 032, cancer, homogenized [OPG study]8.3275783
GSM549139patient 042, cancer, homogenized [OPG study]8.2629683
GSM549099patient 107, normal, homogenized [OPG study]9.4508592
GSM549109patient 139, normal, homogenized [OPG study]8.7053787
GSM549110patient 046, normal, homogenized [OPG study]9.6211792
GSM549114patient 063, normal, homogenized [OPG study]9.2792990
GSM549122patient 082, normal, homogenized [OPG study]8.5934786
GSM549134patient 033, cancer, homogenized [OPG study]8.2216583
GSM549136patient 036, cancer, homogenized [OPG study]7.8384979
GSM549140patient 044, cancer, homogenized [OPG study]8.1830582
GSM549111patient 047, normal, homogenized [OPG study]10.989697
GSM549113patient 057, normal, homogenized [OPG study]10.310194
GSM549132patient 031, cancer, homogenized [OPG study]9.1264390
GSM549137patient 038, cancer, homogenized [OPG study]8.8601388
GSM549142patient 047, cancer, homogenized [OPG study]6.86770
GSM549100patient 110, normal, homogenized [OPG study]9.6743593
GSM549107patient 135, normal, homogenized [OPG study]9.9335693
GSM549115patient 068, normal, homogenized [OPG study]10.012493
GSM549116patient 072, normal, homogenized [OPG study]9.2514490
GSM549120patient 078, normal, homogenized [OPG study]9.4611791
GSM549131patient 030, cancer, homogenized [OPG study]9.0290288
GSM549118patient 074, normal, homogenized [OPG study]9.5406592
GSM549129patient 027, cancer, homogenized [OPG study]5.9838157
GSM549123patient 088, normal, homogenized [OPG study]8.8270687
GSM549124patient 006, cancer, homogenized [OPG study]7.4809777
GSM549126patient 015, cancer, homogenized [OPG study]9.7203693
GSM549128patient 025, cancer, homogenized [OPG study]8.2851783
GSM549103patient 117, normal, homogenized [OPG study]9.0390690
GSM549117patient 073, normal, homogenized [OPG study]9.4489590
GSM549138patient 041, cancer, homogenized [OPG study]8.6602186
GSM549141patient 045, cancer, homogenized [OPG study]8.9725888
GSM549130patient 028, cancer, homogenized [OPG study]8.6113287
GSM549101patient 111, normal, homogenized [OPG study]9.2031890
GSM549105patient 128, normal, homogenized [OPG study]9.0399389
GSM549106patient 134, normal, homogenized [OPG study]9.0806788
GSM549112patient 048, normal, homogenized [OPG study]8.6221586
GSM549125patient 011, cancer, homogenized [OPG study]7.3837476
GSM549127patient 024, cancer, homogenized [OPG study]8.4896685
GSM549135patient 035, cancer, homogenized [OPG study]9.4707291